MARKET WRAP: JSE firms on vaccine news, while Shoprite drops on lockdown sales data

The JSE tracked firmer global markets on Monday after another Covid-19 vaccine developer reported encouraging results from its trials, while Shoprite lost the most on the day.

American biotechnology group Moderna said on Monday that its preliminary phase 3 trial data showed its  Covid-19 vaccine was more than 94% effective — a result CEO Stephane Bancel called a “game changer”.